Literature DB >> 28886457

Competition-derived FRET-switching cationic conjugated polymer-Ir(III) complex probe for thrombin detection.

Chunnuan Du1, Yufang Hu2, Qingqing Zhang1, Zhiyong Guo1, Guoping Ge3, Sui Wang1, Chunyang Zhai1, Mingshan Zhu1.   

Abstract

A novel, label-free and convenient strategy for thrombin assay has been developed based on the fluorescence resonance energy transfer (FRET) from a cationic conjugated polymer (CCP) to Ir(III) complex. The energy donor (CCP) and acceptor (Ir(III) complex) were taken into close proximity through π-π stacking interaction and electrostatic interaction, leading to the occurrence of FRET. However, the introduction of the thrombin aptamer upset the status and blocked the FRET process, but afterwards the reappearance of FRET phenomenon was confirmed by the special binding interaction between aptamer and thrombin, thus achieving the quantitative detection of thrombin. This assay could detect thrombin as low concentration as about 0.05pM and provided a highly specific selectivity among other nonspecific proteins. Moreover, the strategy may allow our platform to provide similar sensitivity toward different targets in an aptamer-structure-independent manner. Furthermore, the assay can be used to detect thrombin in diluted real urine or serum samples with a satisfactory recovery, implying its great potential for rapid detection of thrombin in the clinic.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aptamer; Cationic conjugated polymers; Fluorescence resonance energy transfer; Ir(III) complex; Thrombin

Mesh:

Substances:

Year:  2017        PMID: 28886457     DOI: 10.1016/j.bios.2017.08.016

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  1 in total

Review 1.  Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics.

Authors:  Domenica Musumeci; Chiara Platella; Claudia Riccardi; Federica Moccia; Daniela Montesarchio
Journal:  Cancers (Basel)       Date:  2017-12-20       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.